To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene UBXN6TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
497 supporting clones for gene UBXN6 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
BM792346 Ascites, stomach .a 1 to 295 27 to 320   tiling clone,   294/320
(91 %)
7 diff
(97.9 %id)
BQ712434 Spleen .a 9 to 662 19 to 674       656/949
(69 %)
23 diff
(97.6 %id)
BQ064342 lymph, lymphoma, cell line .a 14 to 831 24 to 842   tiling clone,   819/983
(83 %)
15 diff
(98.5 %id)
BQ642312 lymph, lymphoma, cell line .a 14 to 747 24 to 760       737/974
(75 %)
23 diff
(97.7 %id)
CN258757 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 16 to 410 24 to 417       394/417
(94 %)
8 diff
(98.1 %id)
BQ887286 carcinoma, cell line, Prostate .a 16 to 751 21 to 764       744/940
(79 %)
34 diff
(96.4 %id)
BU541114 carcinoma, cell line, Prostate .a 16 to 743 26 to 756       731/908
(80 %)
21 diff
(97.7 %id)
CN258759 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 19 to 654 22 to 656       635/663
(95 %)
10 diff
(98.5 %id)
BQ948631 epidermoid carcinoma, cell line, lung .a 19 to 747 19 to 748       730/896
(81 %)
29 diff
(96.8 %id)
TI_154186087   .a 20 to 698 761 to 84     Submitted on the opposite strand 678/1078
(62 %)
3 diff
(99.8 %id)
BQ887980 brain, neuroblastoma, cell line .a 21 to 832 22 to 844       823/937
(87 %)
28 diff
(97.1 %id)
CA429095 Cell Line, Chondrosarcoma .a 30 to 697 14 to 678     Submitted on the opposite strand 665/667
(99 %)
10 diff
(98.6 %id)
AI027145 parathyroid gland, parathyroid tumor .a 34 to 439 1 to 403     Submitted on the opposite strand 403/403
(100 %)
17 diff
(95.8 %id)
AI188741 placenta .a 34 to 471 1 to 438   tiling clone, Submitted on the opposite strand 438/438
(100 %)
2 diff
(99.6 %id)
AA404379   .a 35 to 437 1 to 399     Submitted on the opposite strand 399/399
(100 %)
15 diff
(96.3 %id)
AI559373 anaplastic oligodendroglioma, brain .a 35 to 258 1 to 224     Submitted on the opposite strand 224/224
(100 %)
1 diff
(99.6 %id)
NM_025241.2   .a 35 to 1948 1 to 1914 exact RefSeq, AAA   1914/1914
(100 %)
0 diff
(100 %id)
BM764980 Ascites, stomach .a 35 to 699 1 to 664       664/664
(100 %)
2 diff
(99.7 %id)
BM772602 Ascites, stomach .a 35 to 701 1 to 667       667/667
(100 %)
1 diff
(99.9 %id)
AF272893   .a 36 to 1691 1 to 1656 exact     1656/1656
(100 %)
2 diff
(99.9 %id)
BM773274 Ascites, stomach .a 36 to 528 1 to 493       493/493
(100 %)
1 diff
(99.8 %id)
BE670319 carcinoid, lung .a 37 to 559 1 to 523     Submitted on the opposite strand 523/523
(100 %)
1 diff
(99.9 %id)
BE671594 carcinoid, lung .a 37 to 551 1 to 515     Submitted on the opposite strand 515/515
(100 %)
1 diff
(99.9 %id)
BM928352 brain .a 37 to 666 1 to 638       638/1132
(56 %)
36 diff
(96.9 %id)
AI312524 2 pooled tumors (clear cell type), Kidney .a 39 to 289 1 to 251     Submitted on the opposite strand 251/251
(100 %)
6 diff
(97.7 %id)
W37809 parathyroid gland, parathyroid tumor .a 40 to 434 1 to 392     Submitted on the opposite strand 392/394
(99 %)
13 diff
(96.8 %id)
AW015629   .a 40 to 358 15 to 334     Submitted on the opposite strand 320/320
(100 %)
2 diff
(99.4 %id)
BE219445 carcinoid, lung .a 41 to 509 1 to 469     Submitted on the opposite strand 469/469
(100 %)
1 diff
(99.8 %id)
BE326577 carcinoid, lung .a 41 to 559 1 to 519     Submitted on the opposite strand 519/519
(100 %)
1 diff
(99.9 %id)
BE467577 carcinoid, lung .a 41 to 594 1 to 554     Submitted on the opposite strand 554/554
(100 %)
1 diff
(99.9 %id)
AW195401 Kidney .a 45 to 445 24 to 424     Submitted on the opposite strand 401/401
(100 %)
17 diff
(95.8 %id)
CD517004 White Matter .a 45 to 831 1 to 797       797/877
(90 %)
28 diff
(96.9 %id)
AI924637 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .a 46 to 594 1 to 549     Submitted on the opposite strand 549/549
(100 %)
1 diff
(99.9 %id)
BM807295 brain, hippocampus .a 46 to 665 1 to 626       626/1291
(48 %)
15 diff
(98.9 %id)
AL583474 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 48 to 987 6 to 937   fully sequenced,   934/939
(99 %)
17 diff
(98.2 %id)
CN258758 embryonic stem cells, cell lines H1, H7, andH9 .a 51 to 758 1 to 708       708/708
(100 %)
2 diff
(99.8 %id)
BM471474 melanotic melanoma, skin .a 52 to 940 12 to 912       899/1042
(86 %)
41 diff
(96.1 %id)
DR006679 Spleen .a 52 to 719 7 to 675       669/675
(99 %)
8 diff
(98.9 %id)
BM909229 astrocytoma grade IV, cell line, brain .a 53 to 1053 1 to 1013       1013/1089
(93 %)
25 diff
(97.8 %id)
BM564280 brain, medulla .a 53 to 981 20 to 950       931/1066
(87 %)
31 diff
(97.1 %id)
BM927535 lymph, lymphoma, cell line .a 53 to 954 1 to 912       912/1135
(80 %)
32 diff
(97.2 %id)
BQ059817 lymph, lymphoma, cell line .a 53 to 805 1 to 756       756/1061
(71 %)
12 diff
(98.9 %id)
BQ719436 sympathetic trunk .a 55 to 832 1 to 781       781/919
(84 %)
16 diff
(98.3 %id)
BX385405   .a 56 to 992 1 to 937       787/944
(83 %)
55 diff
(94.2 %id)
BE019107 muscle, rhabdomyosarcoma .a 56 to 315 1 to 260       260/260
(100 %)
2 diff
(99.3 %id)
BM924061 pooled colon, kidney, stomach .a 56 to 1027 1 to 975       975/977
(99 %)
24 diff
(97.6 %id)
BQ933594 epidermoid carcinoma, cell line, lung .a 60 to 918 1 to 866       866/929
(93 %)
28 diff
(97.0 %id)
BU849514 ovary, teratocarcinoma, cell line .a 60 to 674 1 to 621       621/1001
(62 %)
11 diff
(99.0 %id)
BU855044 ovary, teratocarcinoma, cell line .a 60 to 831 1 to 774       774/878
(88 %)
6 diff
(99.4 %id)
BM474466 leiomyosarcoma, uterus .a 66 to 825 1 to 763       763/1060
(71 %)
6 diff
(99.5 %id)
BQ108760 astrocytoma grade IV, cell line, brain .a 71 to 628 9 to 566       558/566
(98 %)
8 diff
(98.6 %id)
BM560702 astrocytoma grade IV, cell line, brain .a 73 to 954 1 to 892       892/1018
(87 %)
24 diff
(97.7 %id)
AA297987 lung .a 87 to 306 1 to 220       220/220
(100 %)
3 diff
(98.7 %id)
TI_57177149   .a 90 to 883 57 to 848       792/848
(93 %)
9 diff
(99.0 %id)
AA809734 germinal center B cell .a 91 to 454 1 to 361     Submitted on the opposite strand 361/361
(100 %)
9 diff
(97.6 %id)
BE297706 muscle, rhabdomyosarcoma .a 93 to 752 64 to 749       612/796
(76 %)
41 diff
(94.9 %id)
BI760751 pooled colon, kidney, stomach .a 94 to 810 1 to 714       714/715
(99 %)
6 diff
(99.2 %id)
TI_57147734   .a 94 to 810 32 to 745       714/746
(95 %)
11 diff
(98.6 %id)
BI831100 brain, medulla .a 98 to 883 1 to 784       784/784
(100 %)
5 diff
(99.4 %id)
BM564287 brain, medulla .a 99 to 882 1 to 795       792/1120
(70 %)
19 diff
(98.4 %id)
BX419114 brain, fetal brain .a 100 to 1098 1 to 988   fully sequenced,   988/988
(100 %)
14 diff
(98.6 %id)
TI_57221356   .a 108 to 665 57 to 638       545/758
(71 %)
32 diff
(95.8 %id)
BI758007 brain .a 116 to 622 1 to 523       488/694
(70 %)
24 diff
(96.6 %id)
TI_57198917   .a 143 to 831 32 to 716       685/723
(94 %)
17 diff
(97.7 %id)
BI820557 pooled brain, lung, testis .a 149 to 831 1 to 678       678/685
(98 %)
12 diff
(98.3 %id)
BF237589 leiomyosarcoma cell line, uterus .a 153 to 707 1 to 557       555/822
(67 %)
15 diff
(98.2 %id)
BG325637 Kidney, renal cell adenocarcinoma .a 154 to 903 1 to 751       751/1097
(68 %)
14 diff
(98.8 %id)
BU158131 epidermoid carcinoma, cell line, salivary gland .a 159 to 1052 1 to 901       901/910
(99 %)
9 diff
(99.1 %id)
BQ674656 epidermoid carcinoma, cell line, salivary gland .a 159 to 1007 1 to 864       864/925
(93 %)
34 diff
(96.4 %id)
BU528540 epidermoid carcinoma, cell line, lung .a 171 to 1053 1 to 885       885/941
(94 %)
6 diff
(99.4 %id)
CF140125 CNCAP(3)T-225 cell line, Prostate .a 176 to 624 7 to 455       449/455
(98 %)
0 diff
(100 %id)
BQ072111 brain, neuroblastoma, cell line .a 176 to 1053 1 to 880       880/982
(89 %)
10 diff
(99.0 %id)
TI_154170485   .a 176 to 832 93 to 754       662/1049
(63 %)
19 diff
(98.2 %id)
BQ927706 large cell carcinoma, lung .a 191 to 1105 1 to 917       917/917
(100 %)
13 diff
(98.6 %id)
AA297066 brain, cerebellum .a 192 to 333 1 to 143       143/143
(100 %)
3 diff
(98.0 %id)
AA298035 lung .a 193 to 466 1 to 273       273/275
(99 %)
4 diff
(98.6 %id)
BQ917989 sciatic nerve .a 193 to 961 1 to 777       777/932
(83 %)
16 diff
(98.3 %id)
BM547767 brain, hippocampus .a 208 to 1183 9 to 986       983/1070
(91 %)
24 diff
(97.8 %id)
CD676317 eye, lens .a 213 to 279 1 to 67       67/67
(100 %)
0 diff
(100 %id)
W37108 parathyroid gland, parathyroid tumor .a 214 to 788 580 to 1     Submitted on the opposite strand 580/583
(99 %)
21 diff
(96.4 %id)
BI826216 brain, medulla .a 214 to 1019 1 to 804       804/804
(100 %)
6 diff
(99.3 %id)
CF126298 Chondrosarcoma Lung Metastasis cell lines, lung .a 214 to 883 12 to 682       672/682
(98 %)
6 diff
(99.2 %id)
TI_57173695   .a 214 to 1019 34 to 837       804/837
(96 %)
11 diff
(98.7 %id)
CV569700 cornea, eye .a 214 to 730 9 to 525       517/525
(98 %)
6 diff
(98.9 %id)
TI_154189264   .a 214 to 1172 68 to 1010       897/1080
(83 %)
42 diff
(96.2 %id)
BM020977 astrocytoma grade IV, cell line, brain .a 230 to 1000 1 to 771       771/771
(100 %)
6 diff
(99.3 %id)
BX376045 Neuroblastoma Cot 25-normalized .a 231 to 1118 1 to 887       885/887
(99 %)
10 diff
(98.9 %id)
BM910569 astrocytoma grade IV, cell line, brain .a 231 to 1058 1 to 829       829/1044
(79 %)
15 diff
(98.6 %id)
BM564267 blood, natural killer cells, cell line .a 231 to 982 1 to 761       761/1077
(70 %)
16 diff
(98.6 %id)
BM917762 blood, natural killer cells, cell line .a 231 to 1045 27 to 846       820/1083
(75 %)
22 diff
(98.0 %id)
TI_59389093   .a 231 to 1000 124 to 893       770/770
(100 %)
5 diff
(99.4 %id)
BF742329 breast .a 256 to 421 1 to 169       169/172
(98 %)
17 diff
(90.2 %id)
BE174952 head_neck .a 261 to 572 365 to 55     Submitted on the opposite strand 311/365
(85 %)
0 diff
(100 %id)
TI_1948124380   .a 290 to 912 132 to 756       625/1390
(44 %)
32 diff
(97.7 %id)
CV026762 mixed .a 291 to 946 1 to 653       653/657
(99 %)
7 diff
(99.0 %id)
TI_1948124378   .a 291 to 1340 134 to 1184       1051/1313
(80 %)
60 diff
(95.5 %id)
TI_1948124903   .a 291 to 1332 126 to 1163       1038/1299
(79 %)
36 diff
(97.3 %id)
TI_1948124904   .a 291 to 1246 129 to 1081       955/1405
(67 %)
31 diff
(97.8 %id)
TI_1948124905   .a 291 to 1155 132 to 993       862/1409
(61 %)
33 diff
(97.7 %id)
TI_1948125439   .a 291 to 1240 132 to 1082   tiling clone,   951/1304
(72 %)
26 diff
(98.1 %id)
TI_1948125440   .a 291 to 1332 129 to 1171   AAA   1043/1485
(70 %)
34 diff
(97.8 %id)
TI_1948125441   .a 291 to 1053 134 to 894       761/1379
(55 %)
22 diff
(98.5 %id)
TI_1948125969   .a 291 to 1282 133 to 1119       987/1279
(77 %)
22 diff
(98.3 %id)
TI_1948125970   .a 291 to 1141 128 to 974       847/1396
(60 %)
21 diff
(98.5 %id)
TI_1948125971   .a 291 to 1170 132 to 1019       888/1465
(60 %)
42 diff
(97.2 %id)
BQ892806 epidermoid carcinoma, cell line, salivary gland .a 293 to 1183 1 to 895       895/969
(92 %)
21 diff
(97.9 %id)
BQ889228 epidermoid carcinoma, cell line, salivary gland .a 293 to 1045 1 to 757       757/900
(84 %)
10 diff
(98.9 %id)
BE925459 amnion_normal .a 308 to 711 3 to 407       405/407
(99 %)
15 diff
(96.4 %id)
BF946361 nervous_normal .a 349 to 572 261 to 38       224/261
(85 %)
1 diff
(99.7 %id)
BM549930 astrocytoma grade IV, cell line, brain .a 352 to 1315 28 to 992       965/1013
(95 %)
19 diff
(98.2 %id)
BM910449 astrocytoma grade IV, cell line, brain .a 354 to 1183 1 to 832       832/1038
(80 %)
5 diff
(99.6 %id)
R15261 whole brain .a 356 to 744 1 to 397       395/418
(94 %)
16 diff
(96.2 %id)
Z45518 brain, total brain .a 364 to 664 1 to 300       300/300
(100 %)
2 diff
(99.4 %id)
T09142   .a 364 to 518 1 to 155       155/155
(100 %)
0 diff
(100 %id)
BQ668871 epidermoid carcinoma, cell line, salivary gland .a 367 to 713 1 to 347       347/348
(99 %)
1 diff
(99.8 %id)
BQ668706 epidermoid carcinoma, cell line, salivary gland .a 367 to 1179 1 to 822       822/919
(89 %)
21 diff
(97.8 %id)
BE164777 head_neck .a 368 to 1026 667 to 11     Submitted on the opposite strand 657/667
(98 %)
1 diff
(99.9 %id)
R12100 whole brain .a 371 to 721 1 to 351       351/355
(98 %)
12 diff
(96.7 %id)
CN258756 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .a 377 to 773 1 to 397       397/397
(100 %)
1 diff
(99.8 %id)
AA323826 brain, cerebellum .a 383 to 568 1 to 186       186/186
(100 %)
0 diff
(100 %id)
BM510284 insulinoma, Pancreas .a 383 to 932 1 to 550       550/550
(100 %)
4 diff
(99.3 %id)
CK823672 insulinoma, Pancreas .a 383 to 959 1 to 577       577/577
(100 %)
4 diff
(99.4 %id)
BG288984 bladder, transitional cell papilloma, cell line .a 386 to 1183 1 to 802       802/964
(83 %)
50 diff
(94.9 %id)
BG746426 adenocarcinoma cell line, colon .a 386 to 1139 1 to 753       753/753
(100 %)
3 diff
(99.7 %id)
BI914490 brain .a 386 to 1055 1 to 669       669/669
(100 %)
1 diff
(99.9 %id)
TI_57242916   .a 386 to 1055 38 to 706       669/706
(94 %)
6 diff
(99.2 %id)
BE161454 head_neck .a 392 to 601 1 to 210       210/210
(100 %)
1 diff
(99.6 %id)
BM694742 eye, RPE and Choroid .a 397 to 737 1 to 342       342/342
(100 %)
1 diff
(99.8 %id)
BM016867 astrocytoma grade IV, cell line, brain .a 407 to 1029 1 to 620       620/620
(100 %)
5 diff
(99.2 %id)
TI_59387105   .a 408 to 1029 62 to 680       619/619
(100 %)
4 diff
(99.4 %id)
BM910915 astrocytoma grade IV, cell line, brain .a 409 to 1036 1 to 629       629/1096
(57 %)
7 diff
(99.4 %id)
BF765302 colon_est .a 419 to 671 255 to 5     Submitted on the opposite strand 251/255
(98 %)
1 diff
(99.7 %id)
BF973604 leiomyosarcoma cell line, uterus .a 440 to 1179 1 to 735       733/838
(87 %)
19 diff
(97.8 %id)
TI_1948124383   .a 443 to 1456 1139 to 130       1010/1375
(73 %)
36 diff
(97.4 %id)
CA396241 eye, RPE/choroid .a 457 to 994 1 to 538       538/538
(100 %)
0 diff
(100 %id)
BM050513 eye, normal pigmented retinal epithelium .a 461 to 1083 1 to 628       628/861
(72 %)
12 diff
(98.7 %id)
BF724234 eye, Iris .a 466 to 1040 1 to 575       575/575
(100 %)
0 diff
(100 %id)
H06759 whole brain .a 469 to 896 1 to 435       435/451
(96 %)
17 diff
(96.3 %id)
BE394793 endometrium, adenocarcinoma cell line, uterus .a 485 to 1158 1 to 674       674/704
(95 %)
6 diff
(99.2 %id)
AA312110   .a 493 to 947 1 to 455       455/455
(100 %)
4 diff
(99.2 %id)
AW955123   .a 494 to 1089 1 to 596       596/657
(90 %)
12 diff
(98.2 %id)
BQ717616 sympathetic trunk .a 497 to 1318 1 to 837       837/938
(89 %)
20 diff
(97.9 %id)
TI_1948125973   .a 498 to 1456 1079 to 130       869/1347
(64 %)
18 diff
(98.7 %id)
T62666 Liver .a 514 to 901 1 to 393       393/393
(100 %)
9 diff
(97.8 %id)
BG030981 breast, mammary adenocarcinoma, cell line .a 515 to 1288 1 to 773       773/1130
(68 %)
24 diff
(97.9 %id)
CR617368 fetal brain .a 523 to 1940 1 to 1418       1418/1418
(100 %)
0 diff
(100 %id)
BX440130 brain, fetal brain .a 523 to 1329 1 to 806   fully sequenced,   806/806
(100 %)
4 diff
(99.6 %id)
BF525923 brain, glioblastoma with EGFR amplification .a 539 to 1145 5 to 606       602/606
(99 %)
21 diff
(96.6 %id)
BU147085 eye, normal pigmented retinal epithelium .a 550 to 1398 1 to 856       856/924
(92 %)
15 diff
(98.4 %id)
BQ951874 epidermoid carcinoma, cell line, lung .a 553 to 1316 1 to 776       776/953
(81 %)
15 diff
(98.5 %id)
TI_1948124382   .a 567 to 1456 1025 to 129       897/1407
(63 %)
22 diff
(98.5 %id)
CA454004   .a 571 to 1345 1 to 777       777/878
(88 %)
12 diff
(98.7 %id)
CA454006   .a 571 to 1447 1 to 887       887/887
(100 %)
16 diff
(98.2 %id)
CA454020   .a 571 to 1421 1 to 857       857/857
(100 %)
10 diff
(98.9 %id)
TI_1948124381   .a 572 to 1456 1024 to 130       895/1356
(66 %)
39 diff
(97.2 %id)
TI_1948124906   .a 572 to 1456 1014 to 127       888/1297
(68 %)
19 diff
(98.6 %id)
TI_1948124907   .a 572 to 1456 1014 to 130       885/1343
(65 %)
9 diff
(99.4 %id)
TI_1948125442   .a 572 to 1456 1018 to 128       891/1336
(66 %)
22 diff
(98.4 %id)
TI_1948125443   .a 572 to 1456 1015 to 131       885/1404
(63 %)
18 diff
(98.8 %id)
TI_1948125972   .a 572 to 1456 1022 to 127       896/1391
(64 %)
25 diff
(98.3 %id)
TI_154162775   .a 572 to 1326 819 to 65     Submitted on the opposite strand 755/1230
(61 %)
10 diff
(99.2 %id)
BG334037 melanotic melanoma, skin .a 573 to 1334 1 to 773       691/866
(79 %)
53 diff
(93.9 %id)
BC007414 Skin, melanotic melanoma. .a 575 to 1948 1 to 1374   tiling clone, available from MGC, AAA   1374/1374
(100 %)
0 diff
(100 %id)
TI_1948124908   .a 576 to 1456 1010 to 132       879/1347
(65 %)
12 diff
(99.2 %id)
TI_1948125444   .a 576 to 1456 1008 to 129       880/1341
(65 %)
11 diff
(99.2 %id)
TI_1948125974   .a 576 to 1456 1012 to 130       883/1398
(63 %)
16 diff
(98.9 %id)
CF128543 Chondrosarcoma Lung Metastasis cell lines, lung .a 591 to 1303 1 to 713       713/713
(100 %)
1 diff
(99.9 %id)
CD673350 eye, Iris .a 594 to 1041 1 to 448       448/448
(100 %)
0 diff
(100 %id)
BE276882 melanotic melanoma, skin .a 604 to 1111 12 to 525       514/526
(97 %)
15 diff
(97.2 %id)
EH338716   .a 605 to 663 1 to 59       59/61
(96 %)
1 diff
(98.4 %id)
CR979813 T-Lymphocytes .a 613 to 1447 1 to 840       840/841
(99 %)
9 diff
(99.0 %id)
BI517316 pooled colon, kidney, stomach .a 615 to 1375 1 to 769       769/816
(94 %)
10 diff
(98.8 %id)
TI_45235525   .a 615 to 1375 68 to 836       769/883
(87 %)
16 diff
(98.2 %id)
BG680372 skin, squamous cell carcinoma .a 620 to 1272 1 to 653       653/653
(100 %)
0 diff
(100 %id)
BF989906 placenta_normal .a 635 to 769 1 to 135       135/143
(94 %)
6 diff
(95.9 %id)
BE164102 head_neck .a 640 to 797 172 to 14     Submitted on the opposite strand 159/173
(91 %)
6 diff
(96.6 %id)
W40387 Pancreas, pancreatic islet .a 648 to 1017 1 to 367       367/367
(100 %)
4 diff
(99.0 %id)
BF792562 adrenal cortex carcinoma, cell line, adrenal gland .a 694 to 1320 1 to 627       627/627
(100 %)
0 diff
(100 %id)
BX370741   .a 704 to 1641 1 to 931       933/934
(99 %)
16 diff
(98.3 %id)
BM696364 eye, lens .a 706 to 1132 1 to 427   fully sequenced,   427/427
(100 %)
0 diff
(100 %id)
BM704812 eye, RPE and Choroid .a 709 to 1348 1 to 640   fully sequenced,   640/640
(100 %)
0 diff
(100 %id)
BE207281 lung, small cell carcinoma .a 714 to 1203 1 to 491       491/491
(100 %)
4 diff
(99.2 %id)
BM020857 astrocytoma grade IV, cell line, brain .a 714 to 1335 1 to 629       629/756
(83 %)
16 diff
(97.9 %id)
BM549090 astrocytoma grade IV, cell line, brain .a 715 to 1635 1 to 926       926/1148
(80 %)
33 diff
(97.2 %id)
TI_59387817   .a 715 to 1335 113 to 740       628/755
(83 %)
15 diff
(98.1 %id)
BE073451 breast .a 716 to 1324 1 to 606       606/612
(99 %)
19 diff
(96.9 %id)
BM909721 astrocytoma grade IV, cell line, brain .a 716 to 1573 1 to 863       863/1004
(85 %)
20 diff
(98.1 %id)
BQ421398 large cell carcinoma, lung .a 722 to 1049 1 to 328       328/1081
(30 %)
9 diff
(99.2 %id)
BF569513 Kidney, renal carcinoma (ascites) .a 732 to 1272 1 to 540   fully sequenced,   540/540
(100 %)
1 diff
(99.9 %id)
BF569643 Kidney, renal carcinoma (ascites) .a 732 to 1272 1 to 538   fully sequenced,   538/538
(100 %)
4 diff
(99.3 %id)
BE393060 endometrium, adenocarcinoma cell line, uterus .a 734 to 1364 1 to 631       631/633
(99 %)
10 diff
(98.5 %id)
BM720633 eye, fetal eye .a 738 to 1450 1 to 713       713/713
(100 %)
2 diff
(99.8 %id)
BF311144 brain, neuroblastoma .a 743 to 1498 1 to 758       758/946
(80 %)
24 diff
(97.5 %id)
BG491666 amelanotic melanoma, cell line, skin .a 743 to 1526 1 to 791       791/791
(100 %)
15 diff
(98.2 %id)
BM009731 amelanotic melanoma, cell line, skin .a 743 to 1703 1 to 973       973/974
(99 %)
28 diff
(97.2 %id)
BG983560 colon_normal .a 744 to 1115 373 to 1       373/373
(100 %)
5 diff
(98.7 %id)
TI_59384501   .a 744 to 1703 61 to 1032       972/973
(99 %)
27 diff
(97.3 %id)
TI_154188485   .a 744 to 1392 750 to 100     Submitted on the opposite strand 651/1046
(62 %)
12 diff
(98.9 %id)
BM557268 amelanotic melanoma, cell line, skin .a 745 to 1593 1 to 865       865/990
(87 %)
27 diff
(97.3 %id)
BM562398 amelanotic melanoma, cell line, skin .a 745 to 1496 1 to 750       750/1013
(74 %)
12 diff
(98.9 %id)
TI_151765966   .a 745 to 1345 170 to 773   AAA   606/1272
(47 %)
26 diff
(98.0 %id)
BM809615 amelanotic melanoma, cell line, skin .a 747 to 1507 1 to 765       765/1179
(64 %)
19 diff
(98.4 %id)
BM912717 amelanotic melanoma, cell line, skin .a 747 to 1658 1 to 916       916/1045
(87 %)
21 diff
(98.0 %id)
CN391117 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .a 748 to 1282 1 to 535       535/535
(100 %)
0 diff
(100 %id)
BM823035 stomach .a 748 to 1198 1 to 450       450/450
(100 %)
1 diff
(99.8 %id)
BM793658 Ascites, stomach .a 748 to 1271 1 to 524       524/524
(100 %)
11 diff
(98.0 %id)
BM721551 eye, fetal eye .a 751 to 1158 1 to 408       408/408
(100 %)
1 diff
(99.8 %id)
BG698915 skin .a 753 to 1575 1 to 828       828/836
(99 %)
26 diff
(96.9 %id)
BM707792 eye, RPE and Choroid .a 757 to 1186 1 to 430       430/430
(100 %)
0 diff
(100 %id)
BQ346113 nervous_tumor .a 759 to 1307 2 to 544       543/544
(99 %)
23 diff
(95.8 %id)
AW815888 stomach .a 763 to 914 21 to 171       151/172
(87 %)
14 diff
(91.9 %id)
BE615908 adenocarcinoma, Pancreas .a 767 to 1457 1 to 695       695/700
(99 %)
11 diff
(98.5 %id)
BE614753 adenocarcinoma, Pancreas .a 767 to 1568 1 to 798       798/959
(83 %)
17 diff
(98.3 %id)
BE531062 adenocarcinoma, Pancreas .a 769 to 1575 1 to 804       804/834
(96 %)
16 diff
(98.1 %id)
CF134698 CNCAP(3)T-225 cell line, Prostate .a 771 to 1326 568 to 13     Submitted on the opposite strand 556/568
(97 %)
0 diff
(100 %id)
BM703126 eye, human retina .a 772 to 1082 1 to 311   fully sequenced,   311/311
(100 %)
2 diff
(99.4 %id)
BM725150 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 772 to 1213 1 to 442   fully sequenced,   442/442
(100 %)
2 diff
(99.6 %id)
BG680396 skin, squamous cell carcinoma .a 776 to 1677 1 to 896       896/899
(99 %)
22 diff
(97.6 %id)
BM708659 eye, RPE and Choroid .a 778 to 1091 1 to 314       314/314
(100 %)
0 diff
(100 %id)
EC570402 Prostate .a 781 to 888 1 to 107       107/107
(100 %)
2 diff
(98.2 %id)
BE277650 melanotic melanoma, skin .a 791 to 1463 1 to 675       673/740
(90 %)
5 diff
(99.4 %id)
AW793772 uterus .a 801 to 1105 1 to 307       307/307
(100 %)
10 diff
(96.8 %id)
BG684409 B-cells, primary B-cells from tonsils (cell line) .a 808 to 1438 1 to 631       631/631
(100 %)
1 diff
(99.9 %id)
CV319668 pnet .a 831 to 1182 371 to 14     Submitted on the opposite strand 358/382
(93 %)
24 diff
(93.8 %id)
BU616499 Bone, Subchondral Bone .a 831 to 1478 665 to 19   AAA   647/650
(99 %)
2 diff
(99.7 %id)
BX395369 Neuroblastoma Cot 50-normalized .a 834 to 1921 1080 to 1       1080/1080
(100 %)
70 diff
(93.6 %id)
CR598178 Neuroblastoma Cot 25-normalized .a 838 to 1937 1 to 1100       1100/1100
(100 %)
0 diff
(100 %id)
BX355003 Neuroblastoma Cot 25-normalized .a 838 to 1937 1 to 1089   fully sequenced,   1089/1089
(100 %)
26 diff
(97.7 %id)
BG750559 eye, normal pigmented retinal epithelium .a 840 to 1451 1 to 624       624/772
(80 %)
21 diff
(97.3 %id)
BU955955 adenocarcinoma, cell line, breast .a 842 to 1630 1 to 794       794/944
(84 %)
27 diff
(97.2 %id)
BG680209 skin, squamous cell carcinoma .a 859 to 1793 1 to 924       924/928
(99 %)
30 diff
(96.8 %id)
BG327262 Kidney, renal cell adenocarcinoma .a 864 to 1588 1 to 722       722/729
(99 %)
5 diff
(99.4 %id)
BC017113 Uterus, endometrium adenocarcinoma .a 865 to 1943 1 to 1079   available from MGC, AAA   1079/1079
(100 %)
2 diff
(99.9 %id)
BI083866 epidermoid carcinoma, cell line, salivary gland .a 881 to 1272 1 to 394   fully sequenced,   394/394
(100 %)
2 diff
(99.5 %id)
BE378482 endometrium, adenocarcinoma cell line, uterus .a 884 to 1549 1 to 665       665/665
(100 %)
4 diff
(99.4 %id)
BU196197 melanotic melanoma, cell line, skin .a 884 to 1703 1 to 831       831/857
(96 %)
14 diff
(98.4 %id)
BQ674770 epidermoid carcinoma, cell line, salivary gland .a 884 to 1666 1 to 801       801/914
(87 %)
30 diff
(96.8 %id)
BM006830 ductal carcinoma, cell line, Pancreas .a 911 to 1552 1 to 641   fully sequenced,   641/641
(100 %)
3 diff
(99.6 %id)
BM006380 ductal carcinoma, cell line, Pancreas .a 911 to 1636 1 to 725       725/725
(100 %)
17 diff
(97.7 %id)
TI_59395052   .a 911 to 1636 57 to 781       725/725
(100 %)
17 diff
(97.7 %id)
TI_59395322   .a 911 to 1552 61 to 701   fully sequenced,   641/641
(100 %)
3 diff
(99.6 %id)
TI_151708110   .a 934 to 1494 682 to 126   AAA   557/694
(80 %)
12 diff
(98.3 %id)
AL519813 brain, neuroblastoma cells, Neuroblastoma Cot 10-normalized .a 957 to 1910 948 to 1   fully sequenced,   948/948
(100 %)
10 diff
(99.0 %id)
BP386241 pancreatic islet .a 960 to 1464 507 to 1       506/508
(99 %)
9 diff
(98.3 %id)
CN484529 eye .a 962 to 1581 1 to 620       620/620
(100 %)
0 diff
(100 %id)
BI763437 pooled colon, kidney, stomach .a 968 to 1629 1 to 659       659/663
(99 %)
15 diff
(97.8 %id)
TI_57149949   .a 968 to 1629 28 to 686       659/690
(95 %)
21 diff
(97.0 %id)
BX363043   .a 971 to 1915 942 to 1       942/952
(98 %)
12 diff
(98.8 %id)
BM753199 stomach .a 981 to 1464 1 to 484       484/484
(100 %)
0 diff
(100 %id)
BM785047 stomach .a 981 to 1377 1 to 397       397/397
(100 %)
0 diff
(100 %id)
BM765685 stomach .a 981 to 1469 1 to 489       489/489
(100 %)
0 diff
(100 %id)
BM766033 stomach .a 981 to 1467 1 to 487       487/487
(100 %)
0 diff
(100 %id)
BM771613 stomach .a 981 to 1201 1 to 221       221/221
(100 %)
0 diff
(100 %id)
BM771684 stomach .a 981 to 1584 1 to 604       604/604
(100 %)
0 diff
(100 %id)
TI_57234033   .a 988 to 1702 28 to 741       714/744
(95 %)
9 diff
(98.8 %id)
BI907665 leukocyte .a 989 to 1702 1 to 713       713/716
(99 %)
3 diff
(99.6 %id)
BI256505 cervical carcinoma cell line, cervix .a 1010 to 1749 1 to 740       740/740
(100 %)
4 diff
(99.5 %id)
BM664625 eye, human retina .a 1021 to 1478 476 to 19   fully sequenced, AAA   458/458
(100 %)
0 diff
(100 %id)
EC495312 Prostate .a 1025 to 1101 1 to 77       77/83
(92 %)
9 diff
(89.2 %id)
EL950001 eyeball .a 1034 to 1196 34 to 195       162/195
(83 %)
7 diff
(96.5 %id)
W45377 Pancreas, pancreatic islet .a 1035 to 1473 440 to 1       440/440
(100 %)
7 diff
(98.5 %id)
BM796584 Ascites, stomach .a 1035 to 1494 1 to 460       460/460
(100 %)
1 diff
(99.8 %id)
BX438980 placenta .a 1049 to 1886 834 to 1       834/915
(91 %)
25 diff
(97.3 %id)
TI_149298012   .a 1052 to 1943 961 to 78   AAA   884/995
(88 %)
13 diff
(98.7 %id)
AI911142 pooled .a 1060 to 1495 442 to 7       436/442
(98 %)
0 diff
(100 %id)
DB511559 testis .a 1063 to 1495 1 to 433     Submitted on the opposite strand 433/433
(100 %)
7 diff
(98.4 %id)
BX455025 brain, fetal brain .a 1069 to 1947 883 to 1   fully sequenced,   883/883
(100 %)
29 diff
(96.8 %id)
BX412120 placenta .a 1077 to 1936 867 to 6       862/906
(95 %)
17 diff
(98.2 %id)
TI_227712786   .a 1092 to 1943 928 to 89   AAA   840/1002
(83 %)
15 diff
(98.6 %id)
BE387818 endometrium, adenocarcinoma cell line, uterus .a 1093 to 1736 1 to 645       645/645
(100 %)
10 diff
(98.5 %id)
BQ320288 colon .a 1099 to 1519 15 to 437       423/441
(95 %)
9 diff
(98.0 %id)
BM669106 eye, lens .a 1102 to 1494 411 to 19   fully sequenced, AAA   393/393
(100 %)
0 diff
(100 %id)
TI_149301022   .a 1107 to 1948 921 to 86   AAA   836/968
(86 %)
19 diff
(98.1 %id)
TI_149300690   .a 1110 to 1948 890 to 57   AAA   834/985
(84 %)
13 diff
(98.7 %id)
BQ345863 nervous_tumor .a 1114 to 1318 1 to 195       195/197
(98 %)
13 diff
(93.5 %id)
BG744613 blood, natural killer cells, cell line .a 1116 to 1896 779 to 1       779/779
(100 %)
7 diff
(99.2 %id)
BQ638331 eye, retina .a 1117 to 1724 1 to 609       609/609
(100 %)
1 diff
(99.9 %id)
BQ346038 nervous_tumor .a 1120 to 1506 6 to 392       387/392
(98 %)
13 diff
(96.7 %id)
BX352467   .a 1146 to 1936 791 to 5       787/903
(87 %)
14 diff
(98.5 %id)
TI_149293022   .a 1147 to 1943 880 to 97   AAA   784/791
(99 %)
26 diff
(96.8 %id)
BM679770 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .a 1152 to 1478 340 to 14   fully sequenced, AAA   327/327
(100 %)
1 diff
(99.7 %id)
BE882202 leiomyosarcoma, uterus .a 1163 to 1474 1 to 312       312/312
(100 %)
0 diff
(100 %id)
W76480 heart .a 1165 to 1465 1 to 301   fully sequenced,   301/301
(100 %)
6 diff
(98.1 %id)
AA315859 lung .a 1173 to 1453 1 to 281       281/281
(100 %)
2 diff
(99.3 %id)
CN482738 eye .a 1173 to 1593 1 to 421       421/421
(100 %)
6 diff
(98.6 %id)
CN391118 embryonic stem cells, cell lines H1, H7, andH9 .a 1197 to 1384 19 to 206       188/206
(91 %)
6 diff
(97.1 %id)
AI906713 breast .a 1201 to 1378 27 to 204       178/212
(83 %)
9 diff
(95.8 %id)
AI906905 breast .a 1213 to 1364 1 to 152       152/157
(96 %)
4 diff
(97.5 %id)
BX376044 Neuroblastoma Cot 25-normalized .a 1237 to 1916 685 to 1       685/685
(100 %)
15 diff
(97.9 %id)
BX355002 Neuroblastoma Cot 25-normalized .a 1242 to 1921 679 to 1   fully sequenced,   679/679
(100 %)
15 diff
(97.8 %id)
BF570012 Kidney, renal carcinoma (ascites) .a 1242 to 1900 661 to 1   fully sequenced,   661/661
(100 %)
5 diff
(99.3 %id)
BF569983 Kidney, renal carcinoma (ascites) .a 1242 to 1898 659 to 2   fully sequenced,   658/659
(99 %)
0 diff
(100 %id)
BI084538 epidermoid carcinoma, cell line, salivary gland .a 1242 to 1898 663 to 6   fully sequenced,   658/663
(99 %)
0 diff
(100 %id)
BX434521 brain, fetal brain .a 1299 to 1936 643 to 6   fully sequenced,   638/643
(99 %)
0 diff
(100 %id)
BU730369 eye, RPE and Choroid .a 1301 to 1943 661 to 19   fully sequenced, AAA   643/643
(100 %)
0 diff
(100 %id)
BU731252 eye, RPE and Choroid .a 1313 to 1943 649 to 19   AAA   631/631
(100 %)
0 diff
(100 %id)
R58160   .a 1325 to 1482 1 to 156       156/156
(100 %)
9 diff
(94.3 %id)
W72263 heart .a 1351 to 1480 130 to 1   fully sequenced,   130/130
(100 %)
1 diff
(99.3 %id)
CV365862 nervous_normal .a 1371 to 1519 162 to 20     Submitted on the opposite strand 143/162
(88 %)
0 diff
(100 %id)
AJ573504 pectoral muscle (after mastectomy) .a 1375 to 1478 23 to 125   AAA   103/125
(82 %)
6 diff
(95.2 %id)
BM679341 eye, fetal eye .a 1454 to 1948 513 to 17   AAA   497/497
(100 %)
2 diff
(99.6 %id)
BE207844 muscle, rhabdomyosarcoma .a 1508 to 1949 446 to 5   tiling clone,   442/446
(99 %)
0 diff
(100 %id)
BM007142 ductal carcinoma, cell line, Pancreas .a 1522 to 1877 357 to 1   fully sequenced,   357/357
(100 %)
3 diff
(99.2 %id)
TI_59395323   .a 1522 to 1877 357 to 1   fully sequenced,   357/357
(100 %)
3 diff
(99.2 %id)
BM677176 eye, fetal eye .a 1567 to 1943 395 to 19   AAA   377/377
(100 %)
3 diff
(99.3 %id)
T62817 Liver .a 1578 to 1915 338 to 1       338/347
(97 %)
5 diff
(98.6 %id)
BU733301 eye, RPE and Choroid .a 1594 to 1948 373 to 19   AAA   355/355
(100 %)
1 diff
(99.8 %id)
H06710 whole brain .a 1624 to 1948 340 to 13   AAA   328/332
(98 %)
5 diff
(98.5 %id)
Z41212 brain, total brain .a 1657 to 1943 287 to 1       287/287
(100 %)
2 diff
(99.4 %id)
AW615742 lung, small cell carcinoma .a 1734 to 1948 229 to 15   AAA   215/215
(100 %)
1 diff
(99.6 %id)
BC008288 Uterus, endometrium adenocarcinoma .b 1 to 1807 1 to 1807 exact tiling clone, available from MGC, AAA   1807/1807
(100 %)
3 diff
(99.9 %id)
NM_001171091.1   .b 1 to 1812 1 to 1812 exact RefSeq, AAA   1812/1812
(100 %)
0 diff
(100 %id)
BX113739 heart .b 8 to 719 1 to 713       713/713
(100 %)
4 diff
(99.5 %id)
W76016 heart .b 8 to 337 1 to 326       326/328
(99 %)
9 diff
(97.3 %id)
AF272894   .b 10 to 1807 1 to 1798 exact tiling clone, AAA   1798/1798
(100 %)
1 diff
(100.0 %id)
BM545154 ovary (pool of 3) .b 10 to 1045 1 to 1039       1039/1107
(93 %)
13 diff
(98.9 %id)
BE395036 endometrium, adenocarcinoma cell line, uterus .b 20 to 638 1 to 621       621/625
(99 %)
12 diff
(98.1 %id)
BE395963 endometrium, adenocarcinoma cell line, uterus .b 20 to 627 1 to 608       608/608
(100 %)
3 diff
(99.6 %id)
TI_57179987   .b 57 to 839 29 to 818       790/1073
(73 %)
25 diff
(97.7 %id)
BI772414 pooled lung and spleen .b 61 to 839 1 to 786       786/1041
(75 %)
19 diff
(98.2 %id)
CR590857 B cells (Ramos cell line) Cot 25-normalized .c 1 to 1613 2 to 1614 exact tiling clone,   1614/1614
(100 %)
0 diff
(100 %id)
TI_149309829   .c 826 to 1586 846 to 91   AAA   756/944
(80 %)
7 diff
(99.3 %id)
TI_151744618   .c 837 to 1600 854 to 96   AAA   759/914
(83 %)
20 diff
(97.9 %id)
BI857278 breast, mammary adenocarcinoma, cell line .c 839 to 1605 793 to 20   AAA Submitted on the opposite strand 774/792
(97 %)
34 diff
(95.8 %id)
TI_57187579   .c 839 to 1605 903 to 130   AAA Submitted on the opposite strand 774/792
(97 %)
34 diff
(95.8 %id)
BX352634   .c 844 to 1591 751 to 1       751/877
(85 %)
26 diff
(97.1 %id)
CA309386 Alveolar Macrophage, lung .c 849 to 1600 770 to 19   AAA   752/752
(100 %)
0 diff
(100 %id)
BF344681 brain, glioblastoma with EGFR amplification .c 850 to 1390 29 to 571       543/571
(95 %)
8 diff
(98.6 %id)
BI857061 breast, mammary adenocarcinoma, cell line .c 853 to 1605 777 to 22   AAA Submitted on the opposite strand 756/756
(100 %)
33 diff
(95.7 %id)
TI_57186704   .c 853 to 1605 825 to 70   AAA Submitted on the opposite strand 756/756
(100 %)
33 diff
(95.7 %id)
BI518020 pooled colon, kidney, stomach .c 855 to 1536 712 to 1       672/713
(94 %)
35 diff
(95.1 %id)
CD556546 brain, Pituitary .c 855 to 1534 30 to 715       686/968
(70 %)
27 diff
(97.3 %id)
TI_45235718   .c 855 to 1536 712 to 1       672/713
(94 %)
35 diff
(95.1 %id)
CD742826 Alveolar Macrophage, lung .c 859 to 1600 758 to 19   AAA   740/740
(100 %)
3 diff
(99.6 %id)
AI903128 breast .c 861 to 1220 367 to 8       360/367
(98 %)
0 diff
(100 %id)
AA446402   .c 867 to 1354 1 to 481       481/481
(100 %)
9 diff
(98.2 %id)
CB851300 lung .c 892 to 1586 709 to 15   AAA   695/695
(100 %)
2 diff
(99.8 %id)
BM829822 stomach .c 907 to 1520 1 to 614       614/614
(100 %)
1 diff
(99.9 %id)
BU629511 cell lines, Chondrosarcoma .c 917 to 1605 703 to 19   AAA   685/686
(99 %)
9 diff
(98.7 %id)
BM982991 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 920 to 1600 699 to 19   AAA   681/681
(100 %)
1 diff
(99.9 %id)
BM696371 eye, lens .c 933 to 1600 1 to 668   AAA   668/668
(100 %)
1 diff
(99.9 %id)
BI262476 lymph, lymphoma, cell line .c 935 to 1555 620 to 1       620/620
(100 %)
5 diff
(99.2 %id)
CA946458 eye, lacrimal gland .c 936 to 1569 634 to 1     Submitted on the opposite strand 634/637
(99 %)
4 diff
(99.4 %id)
BQ004449 Chondrosarcoma, Left Pelvis .c 938 to 1605 685 to 17   AAA   669/669
(100 %)
3 diff
(99.6 %id)
TI_57200478   .c 938 to 1607 98 to 765       668/996
(67 %)
9 diff
(99.1 %id)
TI_57200551   .c 938 to 1605 27 to 691       665/901
(73 %)
10 diff
(98.9 %id)
BM982341 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 938 to 1605 684 to 17   AAA   668/668
(100 %)
0 diff
(100 %id)
CB850859 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 938 to 1605 685 to 17   AAA   669/669
(100 %)
2 diff
(99.8 %id)
BM976986 lung, Primary Lung Cystic Fibrosis EpithelialCells .c 938 to 1605 686 to 17   AAA   670/670
(100 %)
4 diff
(99.5 %id)
BM669113 eye, lens .c 939 to 1600 681 to 19   AAA   663/663
(100 %)
2 diff
(99.7 %id)
BQ574015 Chondrosarcoma Grade II, Left Pelvis .c 939 to 1605 686 to 19   AAA   668/668
(100 %)
1 diff
(99.9 %id)
BI821402 pooled brain, lung, testis .c 942 to 1605 1 to 661       661/700
(94 %)
5 diff
(99.3 %id)
BI821329 pooled brain, lung, testis .c 942 to 1607 1 to 664       664/696
(95 %)
5 diff
(99.3 %id)
BY798817 eye .c 945 to 1469 1 to 525       525/525
(100 %)
1 diff
(99.9 %id)
BF037604 adenocarcinoma, ovary .c 945 to 1600 1 to 655       655/655
(100 %)
9 diff
(98.7 %id)
BM810515 astrocytoma grade IV, cell line, brain .c 947 to 1605 1 to 659   AAA   659/659
(100 %)
0 diff
(100 %id)
AA128321 uterus .c 954 to 1425 1 to 458       458/462
(99 %)
26 diff
(94.4 %id)
CR985469 T-Lymphocytes .c 962 to 1464 1 to 503       503/504
(99 %)
2 diff
(99.7 %id)
BX343160   .c 985 to 1537 606 to 39       568/885
(64 %)
0 diff
(100 %id)
BF311591 brain, neuroblastoma .c 985 to 1606 676 to 36     Submitted on the opposite strand 641/847
(75 %)
0 diff
(100 %id)
BQ003850 Chondrosarcoma, Left Pelvis .c 988 to 1600 631 to 19   AAA   613/614
(99 %)
2 diff
(99.7 %id)
BX393363   .c 989 to 1613 626 to 1       626/740
(84 %)
22 diff
(97.1 %id)
CA431785 Bone, Subchondral Bone .c 998 to 1600 621 to 19   AAA   603/603
(100 %)
2 diff
(99.7 %id)
BQ015526 Chondrosarcoma, Left Pelvis .c 1000 to 1600 619 to 19   AAA   601/601
(100 %)
11 diff
(98.2 %id)
BU634252 cell lines, Chondrosarcoma .c 1019 to 1605 604 to 19   AAA   586/586
(100 %)
5 diff
(99.2 %id)
AJ709352 heart .c 1024 to 1556 1 to 533       533/533
(100 %)
2 diff
(99.7 %id)
BQ005569 Chondrosarcoma, Left Pelvis .c 1026 to 1605 599 to 19   AAA   581/581
(100 %)
14 diff
(97.6 %id)
AA128078 uterus .c 1030 to 1280 1 to 250   fully sequenced,   250/250
(100 %)
9 diff
(96.4 %id)
BE547690 cervical carcinoma cell line, cervix .c 1031 to 1600 1 to 569       569/901
(63 %)
8 diff
(99.2 %id)
BQ187356 eye, fetal eyes, lens, eye anterior segment,optic nerve, retina, Retina Foveal and Macular, RPE andChoroid .c 1032 to 1600 1 to 569   AAA   569/569
(100 %)
0 diff
(100 %id)
TI_151734336   .c 1032 to 1600 662 to 94   AAA   569/962
(59 %)
0 diff
(100 %id)
BQ771648 Chondrosarcoma Grade II, Left Pelvis .c 1033 to 1605 590 to 17   AAA   574/584
(98 %)
1 diff
(99.9 %id)
BX351307 Neuroblastoma Cot 50-normalized .c 1043 to 1610 572 to 3       570/620
(91 %)
0 diff
(100 %id)
CD672543 eye, Iris .c 1066 to 1586 1 to 521       521/521
(100 %)
0 diff
(100 %id)
BG393211 embryonal carcinoma, cell line, testis .c 1068 to 1601 1 to 533       533/549
(97 %)
2 diff
(99.7 %id)
BU617190 Bone, Subchondral Bone .c 1075 to 1605 549 to 19   AAA   531/531
(100 %)
2 diff
(99.7 %id)
AI130681 heart .c 1081 to 1602 525 to 4       522/525
(99 %)
0 diff
(100 %id)
AI197957 anaplastic oligodendroglioma, brain .c 1081 to 1605 525 to 1       525/534
(98 %)
4 diff
(99.3 %id)
BM855114 Ascites, stomach .c 1081 to 1416 1 to 336       336/336
(100 %)
0 diff
(100 %id)
AI805319 pooled .c 1082 to 1601 520 to 1       520/520
(100 %)
0 diff
(100 %id)
BG060098 brain, glioblastoma without EGFR amplification .c 1088 to 1600 514 to 1       514/514
(100 %)
3 diff
(99.5 %id)
AW439254 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .c 1107 to 1606 500 to 1       500/500
(100 %)
3 diff
(99.4 %id)
AI022930 senescent fibroblast .c 1108 to 1602 490 to 7       484/569
(85 %)
0 diff
(100 %id)
BU619373 cell lines, Chondrosarcoma .c 1112 to 1605 510 to 19   AAA   492/492
(100 %)
26 diff
(94.8 %id)
CR736766 heart .c 1116 to 1573 1 to 458       458/458
(100 %)
0 diff
(100 %id)
BF223400 carcinoid, lung .c 1123 to 1602 481 to 2       480/481
(99 %)
0 diff
(100 %id)
AI276003 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .c 1125 to 1602 483 to 6       478/483
(98 %)
0 diff
(100 %id)
AI682257 pooled .c 1130 to 1602 474 to 2       473/474
(99 %)
0 diff
(100 %id)
AI271921 Kidney .c 1133 to 1600 468 to 1       468/468
(100 %)
2 diff
(99.6 %id)
AW006128 anaplastic oligodendroglioma, brain .c 1133 to 1605 473 to 1       473/473
(100 %)
2 diff
(99.6 %id)
AA622624 lung, lung tumor .c 1134 to 1572 438 to 1       438/445
(98 %)
7 diff
(98.5 %id)
AI143567 heart .c 1134 to 1606 476 to 4       473/476
(99 %)
0 diff
(100 %id)
AI190542   .c 1134 to 1605 488 to 17   AAA   472/472
(100 %)
1 diff
(99.8 %id)
BE348974 malignant melanoma, metastatic to lymphnode, skin .c 1134 to 1606 477 to 5       473/477
(99 %)
0 diff
(100 %id)
AA557401 breast .c 1135 to 1600 465 to 1       465/465
(100 %)
2 diff
(99.6 %id)
AW274175 pooled .c 1135 to 1602 471 to 4       468/471
(99 %)
0 diff
(100 %id)
AI031827 parathyroid gland, parathyroid tumor .c 1136 to 1602 470 to 4       467/470
(99 %)
0 diff
(100 %id)
AI798043 B-cell, chronic lymphotic leukemia .c 1136 to 1602 471 to 5       467/471
(99 %)
0 diff
(100 %id)
AI862624 B-cell, chronic lymphotic leukemia .c 1136 to 1606 473 to 3       471/473
(99 %)
0 diff
(100 %id)
AA635631 normal prostate, Prostate .c 1140 to 1605 477 to 11   AAA   467/467
(100 %)
4 diff
(99.2 %id)
AA885331 pooled .c 1140 to 1600 473 to 14   AAA   460/460
(100 %)
5 diff
(99.0 %id)
AA812275 invasive tumor (cell line), Prostate .c 1141 to 1572 429 to 1       429/429
(100 %)
8 diff
(98.2 %id)
AA542957 normal prostate, Prostate .c 1142 to 1605 465 to 1       465/465
(100 %)
8 diff
(98.3 %id)
AI086401 anaplastic oligodendroglioma, brain .c 1142 to 1605 464 to 1       464/464
(100 %)
2 diff
(99.6 %id)
AW303440 pooled .c 1146 to 1606 463 to 3       461/463
(99 %)
0 diff
(100 %id)
AI423118 brain, glioblastoma (pooled) .c 1149 to 1600 452 to 1       452/452
(100 %)
3 diff
(99.4 %id)
AI191353 lung .c 1153 to 1600 447 to 1       447/447
(100 %)
4 diff
(99.2 %id)
AI986386 colon, colonic mucosa from 3 patients with Crohn'sdisease .c 1153 to 1600 460 to 13   AAA   448/448
(100 %)
5 diff
(98.9 %id)
AI858948 anaplastic oligodendroglioma, brain .c 1155 to 1605 451 to 1       451/451
(100 %)
0 diff
(100 %id)
BF941212 dorsal root ganglia .c 1155 to 1602 449 to 2       448/449
(99 %)
0 diff
(100 %id)
AA977290 2 pooled tumors (clear cell type), Kidney .c 1156 to 1602 446 to 2       445/446
(99 %)
0 diff
(100 %id)
AW338627 adenocarcinoma, Pancreas .c 1165 to 1606 447 to 6       442/447
(98 %)
0 diff
(100 %id)
DW442943 Liver .c 1166 to 1381 17 to 232       216/232
(93 %)
6 diff
(97.5 %id)
F25322 pectoral muscle (after mastectomy) .c 1170 to 1458 1 to 286       286/286
(100 %)
3 diff
(99.0 %id)
BM508109 insulinoma, Pancreas .c 1173 to 1600 443 to 16   AAA   428/428
(100 %)
2 diff
(99.6 %id)
AI281963 carcinoid, lung .c 1177 to 1599 423 to 1       423/423
(100 %)
2 diff
(99.6 %id)
AW338643 adenocarcinoma, Pancreas .c 1177 to 1606 435 to 6       430/435
(98 %)
0 diff
(100 %id)
AA766569 germinal center B cell .c 1182 to 1600 428 to 11       418/428
(97 %)
0 diff
(100 %id)
AI624153 adenocarcinoma, Pancreas .c 1186 to 1605 420 to 1       420/420
(100 %)
4 diff
(99.1 %id)
W74180 heart .c 1190 to 1600 435 to 25   AAA   411/411
(100 %)
4 diff
(99.1 %id)
AA595903 breast, breast tumor .c 1191 to 1602 412 to 1       412/412
(100 %)
6 diff
(98.6 %id)
BE328413 2 pooled Wilms' tumors, one primary and onemetastatic to brain, Kidney .c 1194 to 1606 413 to 1       413/413
(100 %)
3 diff
(99.3 %id)
BU752262 placenta .c 1194 to 1605 429 to 18   AAA   412/412
(100 %)
2 diff
(99.6 %id)
AI818074 lymph node, lymphoma, follicular mixed small and largecell .c 1196 to 1605 410 to 1       410/410
(100 %)
3 diff
(99.3 %id)
AI360704 pooled germ cell tumors .c 1197 to 1602 412 to 7       406/443
(91 %)
0 diff
(100 %id)
AA352356   .c 1198 to 1537 1 to 337       337/337
(100 %)
5 diff
(98.6 %id)
AW964041   .c 1199 to 1603 1 to 405       405/464
(87 %)
13 diff
(97.2 %id)
W57897 heart .c 1201 to 1600 404 to 1       404/405
(99 %)
8 diff
(98.1 %id)
AW874013 follicular carcinoma, thyroid .c 1202 to 1602 408 to 8       401/408
(98 %)
0 diff
(100 %id)
AW293034   .c 1208 to 1600 410 to 18   AAA   393/393
(100 %)
2 diff
(99.5 %id)
BU735022 eye, lens .c 1217 to 1600 402 to 19   AAA   384/384
(100 %)
1 diff
(99.8 %id)
BF436395 breast, invasive ductal carcinoma, 3 pooled samples .c 1222 to 1606 386 to 2       385/390
(98 %)
0 diff
(100 %id)
AA335568 epididymis .c 1224 to 1599 1 to 385       385/387
(99 %)
19 diff
(95.1 %id)
AA552610 colon, tumor .c 1225 to 1604 379 to 1       379/379
(100 %)
1 diff
(99.8 %id)
AA483512 colon .c 1226 to 1602 379 to 3       377/379
(99 %)
0 diff
(100 %id)
AI208462   .c 1228 to 1606 383 to 3       381/383
(99 %)
0 diff
(100 %id)
AV695334 hepatocellular carcinoma .c 1238 to 1605 1 to 362   AAA   362/362
(100 %)
23 diff
(93.7 %id)
T69596 Liver .c 1239 to 1572 329 to 1       329/329
(100 %)
8 diff
(97.6 %id)
AI014686   .c 1240 to 1589 350 to 1       350/350
(100 %)
2 diff
(99.5 %id)
AA678860   .c 1241 to 1606 364 to 8       357/364
(98 %)
0 diff
(100 %id)
AI267972 carcinoid, lung .c 1241 to 1605 365 to 1       365/365
(100 %)
3 diff
(99.2 %id)
AI955937 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .c 1242 to 1600 371 to 11   AAA   361/361
(100 %)
2 diff
(99.5 %id)
F29862 pectoral muscle (after mastectomy) .c 1244 to 1585 1 to 341       341/341
(100 %)
3 diff
(99.2 %id)
AI675117 Prostate .c 1249 to 1600 362 to 11   AAA   352/353
(99 %)
3 diff
(99.2 %id)
AA126902 uterus .c 1250 to 1600 357 to 1   fully sequenced,   357/357
(100 %)
6 diff
(98.4 %id)
AI301770 carcinoid, lung .c 1254 to 1599 345 to 1       345/347
(99 %)
7 diff
(98.0 %id)
EC452692 Prostate .c 1260 to 1379 1 to 117       117/117
(100 %)
2 diff
(98.3 %id)
EC569549 Prostate .c 1260 to 1379 1 to 119       119/119
(100 %)
1 diff
(99.2 %id)
AI927535 lung, squamous cell carcinoma, poorlydifferentiated (4 pooled tumors, including primary andmetastatic) .c 1262 to 1605 348 to 1       348/348
(100 %)
10 diff
(97.2 %id)
CD672550 eye, Iris .c 1263 to 1599 391 to 55   AAA   337/359
(93 %)
0 diff
(100 %id)
AI269744 pooled .c 1264 to 1606 345 to 3       343/345
(99 %)
0 diff
(100 %id)
EC525581 Prostate .c 1265 to 1379 10 to 122       113/122
(92 %)
6 diff
(95.1 %id)
AI347307 2 pooled tumors (clear cell type), Kidney .c 1267 to 1600 359 to 26   AAA   334/334
(100 %)
10 diff
(97.1 %id)
AJ573540 pectoral muscle (after mastectomy) .c 1269 to 1599 1 to 330   AAA   330/330
(100 %)
9 diff
(97.3 %id)
AI246600 pharynx, squamous cell carcinoma .c 1273 to 1600 335 to 8       328/335
(97 %)
0 diff
(100 %id)
CK823671 insulinoma, Pancreas .c 1280 to 1519 240 to 1       240/240
(100 %)
9 diff
(96.3 %id)
AI955174 brain, four pooled pituitary adenomas .c 1281 to 1602 323 to 2       322/323
(99 %)
0 diff
(100 %id)
AI521559 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .c 1282 to 1600 365 to 47   AAA   319/319
(100 %)
7 diff
(97.9 %id)
AW090788 brain, tumor, 5 pooled (see description) .c 1283 to 1600 318 to 1       318/318
(100 %)
2 diff
(99.4 %id)
AA552632 colon, tumor .c 1284 to 1600 317 to 1       317/317
(100 %)
1 diff
(99.7 %id)
AW088101 brain, tumor, 5 pooled (see description) .c 1284 to 1606 323 to 1       323/325
(99 %)
2 diff
(99.4 %id)
AA912797 pooled .c 1292 to 1600 323 to 15   AAA   309/309
(100 %)
22 diff
(92.9 %id)
AA969209 pooled .c 1292 to 1602 315 to 5       311/315
(98 %)
0 diff
(100 %id)
AI015021   .c 1292 to 1606 323 to 9       315/323
(97 %)
0 diff
(100 %id)
AI216018 pooled .c 1296 to 1606 312 to 1       312/315
(99 %)
1 diff
(99.7 %id)
AI475101 anaplastic oligodendroglioma, brain .c 1301 to 1606 308 to 2       307/308
(99 %)
0 diff
(100 %id)
BG574476 breast, mammary adenocarcinoma, cell line .c 1302 to 1605 1 to 304   AAA   304/304
(100 %)
2 diff
(99.4 %id)
AA864270 Kidney, kidney tumor .c 1304 to 1606 303 to 1       303/303
(100 %)
1 diff
(99.7 %id)
AA928083 pooled .c 1305 to 1606 304 to 3       302/304
(99 %)
0 diff
(100 %id)
BI496496 cochlea, ear .c 1306 to 1492 7 to 193       187/193
(96 %)
1 diff
(99.5 %id)
AW263104 pooled .c 1313 to 1600 302 to 15   AAA   288/288
(100 %)
12 diff
(95.9 %id)
AA886991 Kidney .c 1324 to 1540 221 to 4       218/221
(98 %)
0 diff
(100 %id)
BF530695 anaplastic oligodendroglioma with 1p/19qloss, brain .c 1337 to 1600 25 to 288   AAA   264/288
(91 %)
6 diff
(98.0 %id)
CF145101 CNCAP(3)T-225 cell line, Prostate .c 1337 to 1586 8 to 257       250/257
(97 %)
5 diff
(98.1 %id)
CF145181 CNCAP(3)T-225 cell line, Prostate .c 1337 to 1605 8 to 276   AAA   269/276
(97 %)
6 diff
(97.9 %id)
BU609113 Human Lung Epithelial cells, lung .c 1337 to 1605 285 to 17   AAA   269/277
(97 %)
2 diff
(99.3 %id)
BQ575223 Chondrosarcoma Grade II, Left Pelvis .c 1337 to 1600 282 to 19   AAA   264/273
(96 %)
0 diff
(100 %id)
AA476849 ovarian tumor, ovary .c 1339 to 1600 29 to 289   AAA   261/289
(90 %)
6 diff
(98.0 %id)
AA775266 whole brain .c 1345 to 1602 261 to 4       258/261
(98 %)
0 diff
(100 %id)
AI358862 brain, glioblastoma (pooled) .c 1346 to 1600 255 to 1       255/255
(100 %)
0 diff
(100 %id)
EC515253 Prostate .c 1352 to 1443 1 to 93       93/93
(100 %)
3 diff
(96.8 %id)
AI355522 ovary, tumor, 5 pooled (see description) .c 1355 to 1600 246 to 1       246/246
(100 %)
3 diff
(98.8 %id)
BG413600 pooled .c 1357 to 1602 249 to 4       246/249
(98 %)
0 diff
(100 %id)
AA586508 bulk germ cell seminoma .c 1359 to 1606 248 to 1       248/248
(100 %)
2 diff
(99.2 %id)
BG236768 brain, glioblastoma with probably TP53 mutation andwithout EGFR amplification .c 1359 to 1606 251 to 1       251/251
(100 %)
3 diff
(98.9 %id)
BQ355431 head_neck .c 1373 to 1601 19 to 250   AAA   232/263
(88 %)
13 diff
(95.1 %id)
AI568817 Prostate .c 1378 to 1605 228 to 1       228/228
(100 %)
0 diff
(100 %id)
AI659173 Prostate .c 1378 to 1605 228 to 1       228/228
(100 %)
0 diff
(100 %id)
AI682078 serous papillary carcinoma, high grade, 2pooled tumors, uterus .c 1382 to 1600 240 to 22   AAA   219/219
(100 %)
3 diff
(98.7 %id)
ES311263 frontal balding hair, skin .c 1383 to 1605 223 to 1     Submitted on the opposite strand 223/224
(99 %)
2 diff
(99.2 %id)
BE893829 melanotic melanoma, skin .c 1430 to 1586 1 to 158   AAA   158/158
(100 %)
4 diff
(97.5 %id)
AA833520   .c 1438 to 1593 156 to 1       156/156
(100 %)
2 diff
(98.8 %id)
AA885179 pooled .c 1438 to 1593 156 to 1       156/156
(100 %)
2 diff
(98.8 %id)
BG271637 normal head/neck tissue .c 1444 to 1606 171 to 9       163/199
(81 %)
0 diff
(100 %id)
EC440191 Prostate .c 1507 to 1591 105 to 21       85/105
(80 %)
0 diff
(100 %id)
AW302732 ovary, papillary serous carcinoma .c 1513 to 1593 12 to 92     Submitted on the opposite strand 81/92
(88 %)
8 diff
(91.4 %id)
AW301562 invasive adenocarcinoma, lung .c 1513 to 1595 12 to 94     Submitted on the opposite strand 83/94
(88 %)
6 diff
(93.7 %id)
AI310286 adenocarcinoma, breast .c 1516 to 1604 1 to 89     Submitted on the opposite strand 89/107
(83 %)
6 diff
(94.4 %id)
BE043135 borderline ovarian carcinoma, ovary .c 1528 to 1595 1 to 68       68/68
(100 %)
2 diff
(97.1 %id)
AA923235 pooled .c 1534 to 1602 70 to 2       69/70
(98 %)
0 diff
(100 %id)
AK090473 Spleen .d-u 1 to 4598 1 to 4600 C58W H91S S92Q R93Q G94R ... tiling clone, available from FLJ,   4600/4600
(100 %)
13 diff
(99.8 %id)
BE174474 head_neck .d-u 933 to 1283 22 to 370   tiling clone,   349/374
(93 %)
6 diff
(98.4 %id)
BF942855 nervous_normal .d-u 1469 to 2042 1 to 577       577/577
(100 %)
12 diff
(98.0 %id)
BE243017 leukopheresis .d-u 3726 to 3906 1 to 181       181/181
(100 %)
2 diff
(98.9 %id)
AA371841 pituitary gland .d-u 3911 to 4240 5 to 333       329/333
(98 %)
6 diff
(98.2 %id)
BF981600 duodenal adenocarcinoma, cell line, small intestine .e 1 to 646 1 to 647   tiling clone,   647/944
(68 %)
13 diff
(98.7 %id)
BI199067 brain, neuroblastoma .e 475 to 1139 1 to 665 A90D W210G A211P P212Q L215P ... tiling clone,   665/667
(99 %)
11 diff
(98.4 %id)
BE869061 adenocarcinoma, colon .f 1 to 735 1 to 724 V24W A25P A26T S27P I28S ... tiling clone,   724/934
(77 %)
24 diff
(97.5 %id)
CF126429 Chondrosarcoma Lung Metastasis cell lines, lung .f 411 to 1213 1 to 802   tiling clone,   802/802
(100 %)
4 diff
(99.6 %id)
TI_154189417   .f 411 to 1277 51 to 909       859/994
(86 %)
18 diff
(98.2 %id)
TI_149297240   .f 453 to 1297 925 to 86   tiling clone, AAA   840/936
(89 %)
10 diff
(99.0 %id)
CD675436 eye, lens .g 1 to 403 1 to 403   tiling clone,   403/403
(100 %)
1 diff
(99.8 %id)
CR991505 T-Lymphocytes .g 335 to 957 1 to 623   tiling clone,   623/628
(99 %)
2 diff
(99.7 %id)
AL833695 lymph node .g 683 to 2647 1 to 1965   tiling clone, available from DKFZ, AAA   1965/1965
(100 %)
2 diff
(99.9 %id)
BM546461 brain, hippocampus .g 1472 to 2183 20 to 735       716/739
(96 %)
12 diff
(98.4 %id)
AA142963 uterus Gene UBXN6, variant not shown       fully sequenced, AAA Suspected internal deletion, this clone was ignored    
AA150629 uterus Gene UBXN6, variant not shown       fully sequenced, Suspected internal deletion, this clone was ignored    
AI620464 Prostate Gene UBXN6, variant not shown         Suspected internal deletion, this clone was ignored    
AI869061 Prostate Gene UBXN6, variant not shown         Suspected internal deletion, this clone was ignored    
CB048027 Prostate Gene UBXN6, variant not shown       fully sequenced, AAA Suspected internal deletion, this clone was ignored    
CB048028 Prostate Gene UBXN6, variant not shown       fully sequenced, AAA Suspected internal deletion, this clone was ignored    
BE547278 cervical carcinoma cell line, cervix Gene UBXN6, variant not shown         This clone was ignored    
BI260883 cervical carcinoma cell line, cervix Gene UBXN6, variant not shown         This clone was ignored    
BQ898456 dorsal root ganglia Gene UBXN6, variant not shown         Suspected internal deletion, this clone was ignored    
TI_154194651   Gene UBXN6, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d-u, .e, .f, .g Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes CI